Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
Preferred Name | Didanosine [Chemical/Ingredient] | |
Synonyms |
|
|
ID |
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000006111 |
|
code |
C22566
|
|
Display_Name |
Didanosine
|
|
imported from | ||
label |
Didanosine [Chemical/Ingredient]
|
|
MeSH_CUI |
M0024535
|
|
MeSH_Definition |
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.
|
|
MeSH_DUI |
D016049
|
|
MeSH_Name |
Didanosine
|
|
NUI |
N0000006111
|
|
prefixIRI |
NDF-RT:N0000006111
|
|
prefLabel |
Didanosine [Chemical/Ingredient]
|
|
RxNorm_CUI |
3364
|
|
RxNorm_Name |
Didanosine
|
|
Synonym |
2',3'-Dideoxyinosine ddI (Antiviral) Dideoxyinosine Inosine, 2',3'-dideoxy-
|
|
UMLS_CUI |
C0012133
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping
Mapping To | Ontology | Source |
---|---|---|
http://purl.bioontology.org/ontology/NDFRT/N0000006111 | NDFRT | LOOM |